Medical Equipments, Pharmaceuticals And Personal Care Products Tenders

Drug Discount Contracts with Membership Option - 0075-Rvbeitr.66-2023

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Rotigotine (Atc Code According to Who: N04bc09)

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Dronedarone (Atc Code According to Who: C01bd07)

Order Announcement - Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V for Medicines with the Active Ingredient Rotigotine

Hse Ref: 22409 National Dps Qualification for Beds, Cots, Mattresses and Pressure Relief Equipment

Open House Originals Discount Agreements 2023-38 - Propranolol (Dosage Form: Oral Solution)

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Maraviroc, Atc J05ax09 for the Period January 1St, 2024 - December 31St, 2025

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Paliperidone (Exclusively 3-Month Depot), Atc N05ax13 for the Period January 1St, 2024 - December 31St, 2025

Medicines Called Botox(R) (Atc: M03ax21)

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Interferon Beta-1A (Rebif)